Facebook
Twitter
LinkedIn
ForwardMedical Biochemical Genetics Clinical Core Seminar Series 2025
The series provides a core set of didactic sessions that highlight advanced, practical application of the knowledge of biochemical genetics for all who practice in the field (from trainees to faculty). This series provides a way to bring together clinical team members in the small field of biochemical genetics in order to grow and establish community, share best practices, develop careers, and prepare fellows for board exam and clinical practice.
The Medical Biochemical Genetics Clinical Core Seminar Series is an educational event offered every Friday from 12:00 - 1:30PM MT beginning July 2025. Each session will explore specialized topics in the field of biochemical genetics, featuring talks and discussions from leading pediatric genetics experts.
Recordings of weekly presentations can be found here.
Commercial Supporter
This educational activity is supported by an educational grant from Ultragenyx.
Target Audience
The target audience for this educational series is primarily Medical Biochemical Genetics (clinical) and Clinical Biochemical Genetics (laboratory) Fellows. The course is open to, and has been beneficial for, Medical Genetics and Genomics and combined Pediatric/Genetics Residents, other rotating residents (Pediatrics, Family Medicine, Internal Medicine, etc), students (medical, genetic counseling, etc.), MD/DO/PhD faculty, and other biochemical genetics team members (genetic counselors, dietitians, advanced practice providers).
Learning Objectives
At the conclusion of this educational series, participants should be able to:
- Diagnose and manage inborn errors of metabolism and better understand nuances of rare disorders to prepare for board exams and maintenance of certification.
- Organize and improve inter-professional communication, community, and team-building with others in the MBG field.
- Determine best practices between biochemical genetic faculty experts and trainees.
| Medical Biochemical Genetics 2025 | ||
|---|---|---|
| Date | Topic | Speaker |
| Fatty Acid Oxidation Disorders 1 | Nicola Longo, MD, University of California Los Angeles | |
| Fatty Acid Oxidation Disorders 2 | Nicola Longo, MD, University of California Los Angeles | |
| Amino Acid Disorders 1 | Curtis Coughlin, MD, University of Colorado | |
| Lysosomal Disorders 1 | Bill Wilcox, MD, Emory University | |
| Amino Acid Disorders 2 | Shawn McCandless, MD, University of Colorado | |
| Carbohydrate Metabolism Disorders 1 | Areeg El-Gharbawy, MD, Duke University | |
| Amino Acid Disorders 3 | Nicholas Ah Mew, MD, Children's National Hospital | |
| Carbohydrate Metabolism Disorders 2 | Areeg El-Gharbawy, MD, Duke University | |
| Organic Acidurias 1 | Irini Manoli, MD, National Institute of Health | |
| Clinical Biochemical Laboratory | Tim Wood, MD, University of Colorado | |
| Lipid, Bile Acid and Cholesterol Metabolism Disorders | Robert Steiner, MD, University of Wisconsin | |
| Neurometabolic Disorders 1 | Reid Sutton, MD, Baylor University | |
| Mitochondrial Disorders 1 | Marni Falk, MD, Children's Hospital of Philadelphia | |
| Lysosomal Disorders 2 | Bill Wilcox, MD Emory University | |
| Novel Therapies in IEM | Shawn McCandless, MD University of Colorado | |
| Neurometabolic Disorders 2 | Reid Sutton, MD, Baylor University | |
| Mitochondrial Disorders 2 | Austin Larson, MD, University of Colorado | |
| Congenital Disorders of Glycosylation | Hudson Freeze, MD, Sanford Burnham Presbyterian | |
| Peroxisomal Disorders | Hilary Vernon, MD, Johns Hopkins | |
| Newborn Screening | Shawn McCandless, MD University of Colorado | |
| Organic Acidurias 2 | Oleg Shchelochkov, MD, National Institute of Health | |
*Please check back for updated 2025 information